ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Caplin reported strong Q1FY27 growth with 20% revenue and 19% PAT increase. Management is scaling capacity towards 15+ sterile lines while maintaining a debt-free balance sheet and high cash reserves.
Caplin Point delivers strong Q1FY27 growth driven by a 3x surge in US revenue. Management is aggressive on vertical integration and digitalization but faces near-term capacity constraints at key plants.
Caplin Point reported strong Q4 FY26 results with revenue doubling to INR 2,300cr and liquid assets tripling. Strategy focuses on massive injectable expansion and LATAM private market depth.
Caplin Point delivers a strong FY26 with revenue doubling over five years and a massive push into US injectables.